Stereotypic Behaviors and Feeding Difficulties in Adults With Developmental Disabilities

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOslo University Hospital

About this trial

Adults with developmental disabilities (DD) and autism represent a vulnerable demographic that transitions into adulthood with diverse etiologies, exhibiting a significantly higher prevalence of various challenging behaviors. These problematic behaviors can lead to adverse health outcomes and a diminished quality of life. Addressing these issues often necessitates an interdisciplinary approach to continuity of care, focusing on enhancing functional skills, empowerment, and independence, as well as preventing and mitigating challenging behaviors. The current research proposal comprises of three studies designed to evaluate the efficacy of behavioral interventions for problematic behaviors in adults with DD and autism. If left unaddressed, these behaviors may worsen over time, potentially hindering community involvement, educational opportunities, and employment prospects. These include harmful stereotypies and feeding difficulties.

Eligibility criteria

Qualifiers

Participants will be recruited through referrals at the Department of Neurohabilitation, or from other hospitals in the Oslo Region.

be 18 years or older,

have a DD, autism spectrum disorder or a PDD-NOS diagnosis

and be referred to the specialist habilitation service for adults.

Disqualifiers

If there are medical causes of the participant's behavioral problem or

a reasonable possibility that the referred problem is caused by medical variables

if the client participant receives communal care services and if those are not in accordance with Norwegian standards of services for individuals with DD.

This could include inappropriate staff-to-client ratio,

Trial design

Treatments tested in this trial

  • Fading and chaining combined with differential reinforcement
  • Differential reinforcement of high rate
  • Response interruption with redirection
  • Chained schedules

Treatment groups

8 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Oslo University Hospital

Lead sponsor

Oslo Metropolitan University

Collaborator